Please click here to check who's online and chat with them.

Cancer Detection Multiple Markers Test

Supplier From South Korea (Republic Of Korea)
Feb-01-24

Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests.

Early diagnostic solutions
BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.

Price and Minumum Quantity

Price FOB in USD: NA

Product Model And Origin

Brand: Bertis

Competitive Advantages

  • Proteomics-based blood test solution for early diagnosis of breast cancer
  • Universal primary screening method
  • Provides a quick and accurate solution for early diagnosis

Recent User Reviews

This user has not received any reviews yet!

Verification Status


 
 
Contact Supplier
Renew

More Items Similiar to: Cancer Detection Multiple Markers Test

GOLD Member
Jan-05-22
Supplier From Chonburi, Thailand
GOLD Member
Jan-05-22
Supplier From Chonburi, Thailand
GOLD Member
Jan-05-22
Supplier From Chonburi, Thailand
GOLD Member
Jan-05-22
Supplier From Chonburi, Thailand
GOLD Member
Feb-16-22
Supplier From Busan, South Korea (Republic Of Korea)
GOLD Member
Nov-14-19
Supplier From Busan, South Korea (Republic Of Korea)
GOLD Member
Nov-29-20
Supplier From Saint-Paul, France
GOLD Member
Sep-28-22
Buyer From Toronto, Ontario, Canada

Verification Status